Literature DB >> 17475791

Catechol O-methyltransferase Val158Met genotype influences frontoparietal activity during planning in patients with Parkinson's disease.

Caroline H Williams-Gray1, Adam Hampshire, Trevor W Robbins, Adrian M Owen, Roger A Barker.   

Abstract

Cognitive dysfunction commonly occurs even in the early stages of Parkinson's disease (PD). Impairment on frontostriatally based executive tasks is particularly well described but affects only a proportion of early PD patients. Our previous work suggests that a common functional polymorphism (val(158)met) within the catechol O-methyltransferase (COMT) gene underlies some of this executive heterogeneity. In particular, an increasing number of methionine alleles, resulting in lower enzyme activity, is associated with impaired performance on the "Tower of London" planning task. The main objective of this study was to investigate the underlying neural basis of this genotype-phenotype effect in PD using functional magnetic resonance imaging. We scanned 31 patients with early PD who were homozygous for either valine (val) (n = 16) or methionine (met) (n = 15) at the COMT val(158)met polymorphism during performance of an executive task comprising both Tower of London (planning) and simple subtracting ("control") problems. A cross-group comparison between genetic subgroups revealed that response times for planning problems were significantly longer in met compared with val homozygotes, whereas response times for control problems did not differ. Furthermore, imaging data revealed a significant reduction in blood oxygen level-dependent signal across the frontoparietal network involved in planning in met/met compared with val/val patients. Hence, we have demonstrated that COMT genotype impacts on executive function in PD through directly influencing frontoparietal activation. Furthermore, the directionality of the genotype-phenotype effect observed in this study, when interpreted in the context of the existing literature, adds weight to the hypothesis that the relationship between prefrontal function and dopamine levels follows as an inverted U-shaped curve.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17475791      PMCID: PMC6672096          DOI: 10.1523/JNEUROSCI.0774-07.2007

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  53 in total

1.  Mapping the network for planning: a correlational PET activation study with the Tower of London task.

Authors:  A Dagher; A M Owen; H Boecker; D J Brooks
Journal:  Brain       Date:  1999-10       Impact factor: 13.501

Review 2.  D(1) receptors in prefrontal cells and circuits.

Authors:  P S Goldman-Rakic; E C Muly; G V Williams
Journal:  Brain Res Brain Res Rev       Date:  2000-03

3.  The role of the striatum and hippocampus in planning: a PET activation study in Parkinson's disease.

Authors:  A Dagher; A M Owen; H Boecker; D J Brooks
Journal:  Brain       Date:  2001-05       Impact factor: 13.501

4.  Dopamine transporter immunoreactivity in monkey cerebral cortex: regional, laminar, and ultrastructural localization.

Authors:  D A Lewis; D S Melchitzky; S R Sesack; R E Whitehead; S Auh; A Sampson
Journal:  J Comp Neurol       Date:  2001-03-26       Impact factor: 3.215

5.  Physiological dysfunction of the dorsolateral prefrontal cortex in schizophrenia revisited.

Authors:  J H Callicott; A Bertolino; V S Mattay; F J Langheim; J Duyn; R Coppola; T E Goldberg; D R Weinberger
Journal:  Cereb Cortex       Date:  2000-11       Impact factor: 5.357

6.  Schizophrenic subjects activate dorsolateral prefrontal cortex during a working memory task, as measured by fMRI.

Authors:  D S Manoach; D Z Press; V Thangaraj; M M Searl; D C Goff; E Halpern; C B Saper; S Warach
Journal:  Biol Psychiatry       Date:  1999-05-01       Impact factor: 13.382

7.  Visualizing brain activation during planning: the tower of London test adapted for functional MR imaging.

Authors:  R H Lazeron; S A Rombouts; W C Machielsen; P Scheltens; M P Witter; H B Uylings; F Barkhof
Journal:  AJNR Am J Neuroradiol       Date:  2000-09       Impact factor: 3.825

8.  Predictors of nursing home placement in Parkinson's disease: a population-based, prospective study.

Authors:  D Aarsland; J P Larsen; E Tandberg; K Laake
Journal:  J Am Geriatr Soc       Date:  2000-08       Impact factor: 5.562

9.  What contributes to quality of life in patients with Parkinson's disease?

Authors:  A Schrag; M Jahanshahi; N Quinn
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-09       Impact factor: 10.154

10.  Frontal, midbrain and striatal dopaminergic function in early and advanced Parkinson's disease A 3D [(18)F]dopa-PET study.

Authors:  J S Rakshi; T Uema; K Ito; D L Bailey; P K Morrish; J Ashburner; A Dagher; I H Jenkins; K J Friston; D J Brooks
Journal:  Brain       Date:  1999-09       Impact factor: 13.501

View more
  72 in total

Review 1.  Neuroimaging in Parkinson's disease.

Authors:  A Jon Stoessl
Journal:  Neurotherapeutics       Date:  2011-01       Impact factor: 7.620

2.  Impairment of executive performance after transcranial magnetic modulation of the left dorsal frontal-striatal circuit.

Authors:  Odile A van den Heuvel; Helene C Van Gorsel; Dick J Veltman; Ysbrand D Van Der Werf
Journal:  Hum Brain Mapp       Date:  2011-11-11       Impact factor: 5.038

3.  DAT1 and COMT effects on delay discounting and trait impulsivity in male adolescents with attention deficit/hyperactivity disorder and healthy controls.

Authors:  Yannis Paloyelis; Philip Asherson; Mitul A Mehta; Stephen V Faraone; Jonna Kuntsi
Journal:  Neuropsychopharmacology       Date:  2010-08-25       Impact factor: 7.853

4.  Dehydration affects brain structure and function in healthy adolescents.

Authors:  Matthew J Kempton; Ulrich Ettinger; Russell Foster; Steven C R Williams; Gemma A Calvert; Adam Hampshire; Fernando O Zelaya; Ruth L O'Gorman; Terry McMorris; Adrian M Owen; Marcus S Smith
Journal:  Hum Brain Mapp       Date:  2011-01       Impact factor: 5.038

5.  Abnormal brain activation in excoriation (skin-picking) disorder: evidence from an executive planning fMRI study.

Authors:  Brian L Odlaug; Adam Hampshire; Samuel R Chamberlain; Jon E Grant
Journal:  Br J Psychiatry       Date:  2015-07-09       Impact factor: 9.319

6.  The co-occurrence of early onset Parkinson disease and 22q11.2 deletion syndrome.

Authors:  Christina Zaleski; Anne S Bassett; Karen Tam; Andrea L Shugar; Eva W C Chow; Elizabeth McPherson
Journal:  Am J Med Genet A       Date:  2009-03       Impact factor: 2.802

7.  COMT genotype affects prefrontal white matter pathways in children and adolescents.

Authors:  Moriah E Thomason; Robert F Dougherty; Natalie L Colich; Lee M Perry; Elena I Rykhlevskaia; Hugo M Louro; Joachim F Hallmayer; Christian E Waugh; Roland Bammer; Gary H Glover; Ian H Gotlib
Journal:  Neuroimage       Date:  2010-01-18       Impact factor: 6.556

8.  Effects of COMT genotype on sensory gating and its modulation by nicotine: Differences in low and high P50 suppressors.

Authors:  S de la Salle; D Smith; J Choueiry; D Impey; T Philippe; H Dort; A Millar; P Albert; V Knott
Journal:  Neuroscience       Date:  2013-03-25       Impact factor: 3.590

Review 9.  Genes, cognition and brain through a COMT lens.

Authors:  D Dickinson; B Elvevåg
Journal:  Neuroscience       Date:  2009-05-13       Impact factor: 3.590

10.  Functional evaluation of central cholinergic circuits in patients with Parkinson's disease and REM sleep behavior disorder: a TMS study.

Authors:  Raffaele Nardone; Jürgen Bergmann; Francesco Brigo; Monica Christova; Alexander Kunz; Martin Seidl; Frediano Tezzon; Eugen Trinka; Stefan Golaszewski
Journal:  J Neural Transm (Vienna)       Date:  2012-08-19       Impact factor: 3.575

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.